Health In Tech director sells 12K shares

Health In Tech, Inc. director Timothy Hayes reported selling 12,000 shares of Class A Common Stock on September 14, 2026.

Available on EDGAR 09/15/2026 - 04:05 PM EDT Accepted by SEC EDGAR 09/15/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Health In Tech, Inc. director Timothy Hayes reported selling 12,000 shares of Class A Common Stock on September 14, 2026. The weighted average sale price was $0.893 per share, with individual trades between $0.8694 and $0.943. Following this transaction, Hayes holds 108,780 shares directly. No Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Seller: 12,000 shares

Net Sell 1 txn

Insider Hayes Timothy

Role Director

Sold 12,000 shs ($11K)

Share of Position Sold 9.9%

Type	Security	Shares	Price	Value
Sale	Class A Common Stock F1	12,000	$0.893	$11K

Holdings After Transaction: Class A Common Stock — 108,780 shares (Direct)

Holdings Before and After: Class A Common Stock, 120,780 to 108,780 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (1)

1. F1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8694 to $0.943 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 12,000 shares Weighted average sale price: $0.893 per share Sale price range: $0.8694–$0.943 per share +2 more

5 metrics

Shares sold 12,000 shares Class A Common Stock sold by director on September 14, 2026

Weighted average sale price $0.893 per share Average price for the 12,000 HIT shares sold

Sale price range $0.8694–$0.943 per share Range of prices for multiple transactions included in the sale

Shares held after transaction 108,780 shares Director’s direct holdings after the September 14, 2026 sale

Net share change -12,000 shares Net effect of reported insider trading activity in this Form 4

Key Terms

weighted average price, Class A Common Stock, open market or private transaction

3 terms

weighted average price financial

"The reported price in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Class A Common Stock financial

"security title is listed as Class A Common Stock for the transaction"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

open market or private transaction financial

"Transaction code description notes a sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIT report for director Timothy Hayes?

Director Timothy Hayes reported a sale of 12,000 Class A Common Stock shares on September 14, 2026 at a weighted average price of $0.893 per share, with individual trades between $0.8694 and $0.943.

How many Health In Tech (HIT) shares does Timothy Hayes hold after this sale?

After the reported transaction, Timothy Hayes directly holds 108,780 shares of Health In Tech, Inc. Class A Common Stock, according to the filing.

At what prices did Timothy Hayes sell his HIT shares?

The sale used a weighted average price of $0.893 per share. The shares were sold in multiple transactions at prices ranging from $0.8694 to $0.943 per share, inclusive.

Was Timothy Hayes’s HIT share sale under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan was affirmatively checked for this transaction.

What type of HIT security did Timothy Hayes sell in this Form 4?

Timothy Hayes sold Class A Common Stock of Health In Tech, Inc., totaling 12,000 shares in this reported transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hayes Timothy

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FLORIDA 34994

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	09/14/2026		S		12,000(1)	D	$0.893	108,780	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8694 to $0.943 per share, inclusive. The reporting person undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

	/s/ Lori Babcock, as attorney-in-fact for Timothy Hayes	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)